Tom van Wezel

10.7k citations

188 papers · 5.7k indexed · h-index 42

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 61
Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer 88
Oncology top 1%
- Colorectal Cancer Treatments and Studies 23
- Colorectal Cancer Screening and Detection 14
Molecular Biology top 5%
- Epigenetics and DNA Methylation 13
- RNA modifications and cancer 12
Genetics top 2%
- BRCA gene mutations in cancer 16
Endocrinology, Diabetes and Metabolism
- Thyroid Cancer Diagnosis and Treatment 14

Co-authors: Hans Morreau Ronald van Eijk Dina Ruano Jan Oosting Noel F.C.C. de Miranda Frederik J. Hes Marjo van Puijenbroek Vincent T.H.B.M. Smit
Cited by: Cancer Research Pathology and Forensic Medicine Oncology
Journals: BMC Cancer (9 papers)PLoS ONE (9 papers)European Journal of Human Genetics (8 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Tom van Wezel

182 papers receiving 5.7k citations

Peers

Countries citing papers authored by Tom van Wezel

Since Specialization

Citations

This map shows the geographic impact of Tom van Wezel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom van Wezel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom van Wezel more than expected).

Fields of papers citing papers by Tom van Wezel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom van Wezel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom van Wezel. The network helps show where Tom van Wezel may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tom van Wezel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tom van Wezel Line = papers co-authored together Tom van Wezel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Liquid biopsy in BALF is now suitable for clinical practice in patients with suspected NSCLC Lung Cancer ·Sepehr Bozorgzadeh,Chang-Ting Yang,Elisabeth M. P. Steeghs,C. J. Timmer,Бритов Василий Александрович,Lars Strobl,Jasper N. Smit,Ronald van Eijk,Tom van Wezel,好勝守山,D. Cohen	2025	0
2	Constitutional epimutations in LTBP4, a component of the TGF-β signaling, and in BRCA1, as potential drivers of early-onset colorectal cancer Clinical Epigenetics ·Mariona Terradas,Pilar Mur,Hongyu Liu,Darry L. Hadsell,Chiara Maria Lavinia Löffler,A. Freibauer,А.А. Соловьёв,Widya Muliana,Yadav Kumar,Eulene Aparecida Machado,Xosé S. Puente,Gabriel Capellá,Maartje Nielsen,Tom van Wezel,Jakob Nikolas Kather,Conxi Lázaro,Vı́ctor Moreno,Laura Valle	2025	1
3	Improving the diagnosis of leptomeningeal metastases by molecular profiling of cell-free DNA from cerebrospinal fluid European Journal of Cancer ·Qian Luo,Dieta Brandsma,Els Verhoeven,L. Jones Stacy,Kim Monkhorst,Adrianus J. de Langen,Nathan Flores Miranda,Dick Pluim,Tom van Wezel,임보희,Mirjam C. Boelens	2025	1
4	Enrichment of colibactin-associated mutational signatures in unexplained colorectal polyposis patients BMC Cancer ·А.А. Соловьёв,Arnoud Boot,Quinten R. Ducarmon,Sam Nooij,Manon Suerink,Monique E. van Leerdam,Lars Strobl,Carli M.J. Tops,Romy D. Zwittink,Dina Ruano,Alexandra M. J. Langers,Maartje Nielsen,Tom van Wezel,Hans Morreau	2024	5
5	Germline variant affecting p53β isoforms predisposes to familial cancer Nature Communications ·Aperture gallery . Auteur du texte,Dina Ruano,Sebastien M. Joruiz,尚世浩,Yuki FUJITA,David Rood,Veronika J. Brzeski,Mar Rodríguez‐Girondo,Daniela Q.C.M. Barge‐Schaapveld,Maartje Nielsen,Bernadette P. M. van Nesselrooij,Arjen R. Mensenkamp,Monique E. van Leerdam,Thomas H. Sharp,Hans Morreau,Jean‐Christophe Bourdon,Noel F.C.C. de Miranda,Tom van Wezel	2024	1
6	A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differentiation SHILAP Revista de lepidopterología ·Tom J. Harryvan,Lukas J.A.C. Hawinkels,Akin Inderson,Jeanin E. van Hooft,Patrick Micke,J P Mustard,Tom van Wezel,Dinh Thi Hinh,Muhammad Fauzan,А.С. Шарапова,Per‐Göuran Gillberg,Baoyun Sun,Arne Östman,Ludmila OCLANSCHI,Carina Strell,Marten Hornsveld	2022	13
7	Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors British Journal of Cancer ·Li Zhou,Kenneth F. Klopfenstein,Beatriz Carvalho,Tom van Wezel,Gerrit A. Meijer,Martijn Kerst,Michael Schaapveld,Flora E. van Leeuwen,Pétur Snæbjörnsson,Monique E. van Leerdam	2022	2
8	Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk Cancer Research ·Rick A.C.M. Boonen,Wouter W. Wiegant,Mahta Yekkalam,Bas Vroling,M Sinivasan,Zsofia Kote‐Jarai,Martina Mijušković,Simona Cristea,В.А. Рвачёв,Tom van Wezel,Niko Beerenwinkel,Rosalind A. Eeles,Peter Devilee,Maaike P.G. Vreeswijk,Giancarlo Marra,Haico van Attikum	2021	33
9	Neoadjuvant Treatment with Angiogenesis-Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study The Oncologist ·Feng Jung Sherida H. Woei-A-Jin,Nir I. Weijl,Mark C. Burgmans,Arantza Fariña Sarasqueta,Tom van Wezel,Martin N.J.M. Wasser,Minneke J. Coenraad,Jacobus Burggraaf,Susanne Osanto	2021	20
10	B‐cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement American Journal of Hematology ·Paul G. Kemps,Arjen H.G. Cleven,Tom van Wezel,Ronald van Eijk,K Koleichuk,Hendrik Veelken,Peter van Balen,Jean‐Louis Kerkhoffs	2020	3
11	Genomic Characterization of Vulvar (Pre)cancers Identifies Distinct Molecular Subtypes with Prognostic Significance Clinical Cancer Research ·Linda S. Nooij,Natalja T. ter Haar,Dina Ruano,Natalia Rakislova,Tom van Wezel,Vincent T.H.B.M. Smit,Baptist Trimbos,Jaume Ordï,Mariëtte I.E. van Poelgeest,Tjalling Bosse	2017	117
12	Diagnostic value of targeted next-generation sequencing in patients with suspected pancreatic or periampullary cancer Journal of Clinical Pathology ·Babs G. Sibinga Mulder,J. Sven D. Mieog,Arantza Fariña Sarasqueta,Henricus J.M. Handgraaf,Hans F. A. Vasen,Rutger‐Jan Swijnenburg,Saskia Luelmo,Shirin Feshtali,Akin Inderson,Alexander L. Vahrmeijer,Bert A. Bonsing,Tom van Wezel,Hans Morreau	2017	9
13	Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer Science ·Jarno Drost,Ruben van Boxtel,Francis Blokzijl,Tomohiro Mizutani,Nobuo Sasaki,Valentina Sasselli,Joep de Ligt,Sam Behjati,Judith E. Grolleman,Tom van Wezel,Serena Nik‐Zainal,Roland P. Kuiper,Edwin Cuppen,Hans Clevers	2017	312
14	Functional Profiling of Receptor Tyrosine Kinases and Downstream Signaling in Human Chondrosarcomas Identifies Pathways for Rational Targeted Therapy Clinical Cancer Research ·Yixiang Zhang,Jolieke G. van Oosterwijk,Ewa Sicińska,Samuel Moss,Stephen P. Remillard,Tom van Wezel,Claudia Bühnemann,A. Bassim Hassan,George D. Demetri,Judith V.M.G. Bovée,Andrew J. Wagner	2013	75
15	COX-2 expression influences the prognostic effect of aspirin use after diagnosis in colon cancer patients European Journal of Cancer ·Ronnie Gyllentri,Esther Bastiaannet,Ronald van Eijk,Ronald L. P. van Vlierberghe,V.E.P.P. Lemmens,Myrthe P. P. van Herk‐Sukel,Tom van Wezel,Peter J.K. Kuppen,C.J.H. van de Velde,Gerrit‐Jan Liefers	2013	0
16	Infiltration of Lynch Colorectal Cancers by Activated Immune Cells Associates with Early Staging of the Primary Tumor and Absence of Lymph Node Metastases Clinical Cancer Research ·Noel F.C.C. de Miranda,Bryon Cahill,Ekaterina S. Jordanova,Carli M.J. Tops,Frederik J. Hes,Hans F. A. Vasen,Tom van Wezel,Hans Morreau	2012	28
17	Enrichment of Low Penetrance Susceptibility Loci in a Dutch Familial Colorectal Cancer Cohort Cancer Epidemiology Biomarkers & Prevention ·Anneke Middeldorp,Shantie Jagmohan–Changur,Ronald van Eijk,Carli Tops,Peter Devilee,Hans F. A. Vasen,Frederik J. Hes,Richard S. Houlston,Ian Tomlinson,Jeanine J. Houwing‐Duistermaat,Juul Wijnen,Hans Morreau,Tom van Wezel	2009	53
18	Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment Cancer Research ·Yvonne Schrage,Inge H. Briaire‐de Bruijn,Noel F.C.C. de Miranda,Jolieke G. van Oosterwijk,Antonïe H.M. Taminiau,Tom van Wezel,Pancras C.W. Hogendoorn,Judith V.M.G. Bovée	2009	84
19	Progression and Tumor Heterogeneity Analysis in Early Rectal Cancer Clinical Cancer Research ·Esther H. Lips,Ronald van Eijk,Eelco J. R. de Graaf,Pascal G. Doornebosch,Noel F.C.C. de Miranda,Jan Oosting,Tom M. Karsten,Paul H.C. Eilers,Rob A.�E.�M. Tollenaar,Tom van Wezel,Hans Morreau	2008	35
20	Genome-wide Allelic State Analysis on Flow-Sorted Tumor Fractions Provides an Accurate Measure of Chromosomal Aberrations Cancer Research ·Willem E. Corver,Anneke Middeldorp,Natalja T. ter Haar,Ekaterina S. Jordanova,Marjo van Puijenbroek,Ronald van Eijk,Cees J. Cornelisse,Gert Jan Fleuren,Hans Morreau,Jan Oosting,Tom van Wezel	2008	30

About Tom van Wezel

Tom van Wezel is a scholar working on Pathology and Forensic Medicine, Cancer Research, Oncology, Genetics and Reproductive Medicine, having authored 188 papers that have together received 5.7k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (88 papers), Cancer Genomics and Diagnostics (61 papers), Colorectal Cancer Treatments and Studies (23 papers), BRCA gene mutations in cancer (16 papers), Thyroid Cancer Diagnosis and Treatment (14 papers), Colorectal Cancer Screening and Detection (14 papers), Epigenetics and DNA Methylation (13 papers) and RNA modifications and cancer (12 papers). The work is most often cited by research in Cancer Research (1.9k citations), Pathology and Forensic Medicine (1.7k citations), Oncology (2.1k citations), Molecular Biology (2.4k citations) and Genetics (910 citations). Tom van Wezel has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Hans Morreau, Ronald van Eijk, Dina Ruano, Jan Oosting, Noel F.C.C. de Miranda, Frederik J. Hes, Marjo van Puijenbroek, Vincent T.H.B.M. Smit, Willem E. Corver and Gert Jan Fleuren. Their work appears in journals such as BMC Cancer, PLoS ONE, European Journal of Human Genetics, Familial Cancer and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact